<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4608E704-6475-4CCA-AD08-F356E4757A3D"><gtr:id>4608E704-6475-4CCA-AD08-F356E4757A3D</gtr:id><gtr:firstName>Tracy</gtr:firstName><gtr:surname>Hussell</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15072"><gtr:id>FBE951F6-999E-4846-8A8B-8807BB8B955C</gtr:id><gtr:title>Capacity building in single cell inflammation discovery: developing the next generation of scientists</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15072</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Objective: To advance national and international expertise in human single cell analysis by awarding Discovery Fellowships to early career academics who focus on specific cell subsets in health and disease at mucosal barriers.
Our vision is to become an international leader in understanding cell boundaries in human health and disease, for the benefit of patients in Manchester and beyond. The Fellows will ultimately form part of a wider bid for a Centre of Excellence in inflammation.
Rationale: Cellular heterogeneity leads to variability in response of otherwise identical cells to the same stimulus. Examining a single population of cells using pre-defined criteria essentially averages their true complexity. This impairs an understanding of immune health and disease and strategies to alleviate inflammation. Single cell analysis has emerged as the next frontier, removing pre-conceptions on cell phenotype and allowing unbiased definition and discovery.
There are few early academics in this speciality, particularly in the local area. We are ideally placed to support early career fellows and projects containing high risk basic discovery research that is currently precompetitive for external support. We have precedence in recruiting excellent young investigators that rapidly succeed in developing independence.
Approach: Discovery Fellowships will be advertised and successful applicants provided with competitive start-up funds. A call for projects will be advertised internally. They will be embedded in the MRC-funded single cell research centre and aligned to the Manchester Collaborative Centre for inflammation Research that has strong links with GSK and AZ. Ultimately they will demonstrate success in competitive funding, with the security of institutional commitment for a further 12 months.
This approach will prime novel interactions with existing academics, evolve expertise across the North and transform discovery of new medicines and disease mechanisms.</gtr:technicalSummary><gtr:fund><gtr:end>2017-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>750000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1728302</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>December 2016 - November 2021. . Senior Investigator Award in Science, &amp;quot;Pathogenic airway macrophage adaptation in the chronically inflamed lung&amp;quot;.</gtr:description><gtr:end>2021-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>202865/Z/16/Z</gtr:fundingRef><gtr:id>7A1E652E-1FFA-4502-9310-DA01B97644E6</gtr:id><gtr:outcomeId>58ac3a4b441bd8.09645668</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>01E10803-357E-40FA-ADB6-48E2A1AB95C7</gtr:id><gtr:title>Immunopathology of lung diseases: introduction for the special issue.</gtr:title><gtr:parentPublicationTitle>Seminars in immunopathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86142b460f1cf0a7ecf7e1718361b611"><gtr:id>86142b460f1cf0a7ecf7e1718361b611</gtr:id><gtr:otherNames>Hussell T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1863-2297</gtr:issn><gtr:outcomeId>5aa93d0ec896b4.91707574</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B69EED4-C9BB-494F-AD2C-920EBEA687B3</gtr:id><gtr:title>Mutual independence of alkaline- and calcium-mediated signalling in Aspergillus fumigatus refutes the existence of a conserved druggable signalling nexus.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ad2718d9eee59bcdfa6fba55ace7211"><gtr:id>4ad2718d9eee59bcdfa6fba55ace7211</gtr:id><gtr:otherNames>Loss O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>5aaa5132ac79b1.24294640</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12DDE726-C7A1-491E-80CB-ED531D0ADD7F</gtr:id><gtr:title>The role of airway macrophages in apoptotic cell clearance following acute and chronic lung inflammation.</gtr:title><gtr:parentPublicationTitle>Seminars in immunopathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfc10be8a7e89321cdc74cdd1f189cbd"><gtr:id>cfc10be8a7e89321cdc74cdd1f189cbd</gtr:id><gtr:otherNames>Grabiec AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1863-2297</gtr:issn><gtr:outcomeId>5aa93d0e644ed4.84468152</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>599F9C70-1444-4522-982B-CE5E35FCC723</gtr:id><gtr:title>Heterologous immunity meets tissue-specific training.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86142b460f1cf0a7ecf7e1718361b611"><gtr:id>86142b460f1cf0a7ecf7e1718361b611</gtr:id><gtr:otherNames>Hussell T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>5aa93d0e988d76.90217655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7AF2F07-088B-41FD-8793-D5A9DAA75EEF</gtr:id><gtr:title>TLR vaccine adjuvants: closing the stable door before novel influenza strains bolt?</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86142b460f1cf0a7ecf7e1718361b611"><gtr:id>86142b460f1cf0a7ecf7e1718361b611</gtr:id><gtr:otherNames>Hussell T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn><gtr:outcomeId>5aa93d0e3ad5f1.82440674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>115CF730-E43C-4786-B9A2-242DF2084E2B</gtr:id><gtr:title>Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfc10be8a7e89321cdc74cdd1f189cbd"><gtr:id>cfc10be8a7e89321cdc74cdd1f189cbd</gtr:id><gtr:otherNames>Grabiec AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>5aa93d0fb0b191.56777022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA60B26F-71BF-4F9D-88E6-F26763FF6884</gtr:id><gtr:title>Diminished airway macrophage expression of the Axl receptor tyrosine kinase is associated with defective efferocytosis in asthma.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfc10be8a7e89321cdc74cdd1f189cbd"><gtr:id>cfc10be8a7e89321cdc74cdd1f189cbd</gtr:id><gtr:otherNames>Grabiec AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>5aa93d0f2990d6.38619073</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAB5A65C-CC07-4654-A9D6-6A2A001EB438</gtr:id><gtr:title>Anti-Aspergillus Activities of the Respiratory Epithelium in Health and Disease.</gtr:title><gtr:parentPublicationTitle>Journal of fungi (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2988254a9ac0033de46fe5b05392a53e"><gtr:id>2988254a9ac0033de46fe5b05392a53e</gtr:id><gtr:otherNames>Bertuzzi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2309-608X</gtr:issn><gtr:outcomeId>5aaa5132750cb6.42407651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5DBF824-BF45-4617-A456-74116C32E5CE</gtr:id><gtr:title>Progress and prospects of early detection in lung cancer.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51b173b1396087d812f5195f70fe152e"><gtr:id>51b173b1396087d812f5195f70fe152e</gtr:id><gtr:otherNames>Blandin Knight S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>5aa93d0f544c13.12321630</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15072</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>